Preparing for Cell and Gene Therapy 3.0
Patient data is mission-critical data — especially in cell and gene therapy.
In cell and gene therapy (CGT), the patient is the process is the…
Patient data – the unique role in cell and gene therapies (CGTs)
Patient data is mission-critical data — especially in cell and gene therapy.
In cell and gene therapy (CGT), the patient is the process is the…
Patient data – why it is critical for cell and gene therapy stakeholders
The first blog post in this series provided an overview of how the advanced therapies supply chain is different from traditional and biologic drug products…
Patient data – unique challenges, critical uses in the cell therapy value chain
The previous two blog posts in this series provided an overview of why patient-related data matters in cell therapy and gene therapy (CGTs), and how…
Integrated patient data – the future of advanced therapies
The cell and gene therapy (CGT) sector is poised for exponential growth — which will come in novel ways that reflect the unique nature of…
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms…
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
Körber, the leading MES supplier for pharma and biotech, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial…
Life Sciences cybersecurity, knowing your first line of defense and continuously improving it
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Key industry and government regulations provide a cybersecurity foundation in advanced therapies
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Cybersecurity success in advanced therapies starts by prioritizing security as a “Way of working”
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Cybersecurity challenges in advanced therapies — introducing five strategies for success
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing…